• Medicine
  • Published in Neurology 1989

Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies.

@article{Yeh1989PharmacokineticsAB,
  title={Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies.},
  author={Kuang C. Yeh and Thomas F. August and David F. Bush and Kenneth C. Lasseter and Donald G. Musson and Sim{\'o} Schwartz and Michael E. Smith and D. C. Titus},
  journal={Neurology},
  year={1989},
  volume={39 11 Suppl 2},
  pages={
          25-38
        }
}
The pharmacokinetics of Sinemet CR, a controlled-release formulation containing carbidopa and levodopa, were investigated in healthy young and elderly volunteers and in patients with Parkinson's disease. Sinemet CR produced more sustained plasma levels of levodopa, carbidopa, and 3-O methyldopa than did conventional Sinemet. In elderly subjects, the corresponding steady-state plasma levels fluctuated in narrower ranges with Sinemet CR than those following the administration of Sinemet. Results… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 42 CITATIONS

Optimizing extended-release carbidopa/levodopa in Parkinson disease

  • Neurology. Clinical practice
  • 2017
VIEW 2 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics.

  • Movement disorders : official journal of the Movement Disorder Society
  • 2015
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED